Development of lymphopenia at any time during therapy with immune checkpoint inhibitors is associated with poor outcome in metastatic cutaneous melanoma

D. Tomsitz,M. Schlaak, S. Zierold, G. Pesch, T. Schulz, G. Mueller, C. Zecha,L. French,L. Heinzerling

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT(2022)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要